• Clinical outcome metrics: By focusing on treatment quality rather than revenue targets, HCG reduced patient mortality from 3.4% across 5,000 discharges in 2017 to 0.7% across 14,000 discharges.
• Hub-and-spoke expansion: Founded between 2003 and 2005, HCG scaled cancer care nationwide using a hub-and-spoke model by making local practicing oncologists minority partners in cities like Nashik, Vijayawada, and Ahmedabad.
• Equipment financing strategy: To deploy advanced technology affordably, the company negotiated arrangements with equipment manufacturers such as Siemens for three-year payment deferrals until patient volume achieved financial viability.
• Private equity backing: HCG relied on private equity to fund its network expansion, successfully delivering positive returns to seven private equity investors.